𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Response to rituximab in patients with rheumatoid arthritis in different compartments of the immune system

✍ Scribed by Maria J. H. Boumans; Rogier M. Thurlings; Danielle M. Gerlag; Koen Vos; Paul P. Tak


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
220 KB
Volume
63
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Early effects of rituximab on the synovi
✍ Koen Vos; Rogier M. Thurlings; Carla A. Wijbrandts; Dirkjan van Schaardenburg; D πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 202 KB πŸ‘ 2 views

## Abstract ## Objective To study the specific effects of rituximab treatment on the synovium in patients with rheumatoid arthritis (RA) early after initiation of treatment. ## Methods Seventeen RA patients underwent an arthroscopic synovial biopsy procedure directly before and 1 month after rec

Association of the major histocompatibil
✍ Alfonso Martinez; Marina Salido; Gema Bonilla; Dora Pascual-Salcedo; Miguel Fern πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 67 KB πŸ‘ 2 views

## Objective: To determine whether major histocompatibility complex (mhc) polymorphisms are associated with a good or poor response to infliximab therapy in patients with rheumatoid arthritis (ra). ## Methods: Seventy-eight infliximab-treated patients with ra were genotyped for hla-drb1, hla-dqa1

Development of antiinfliximab antibodies
✍ Gerrit Jan Wolbink; Marijn Vis; Willem Lems; Alexandre E. Voskuyl; Els De Groot; πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 80 KB πŸ‘ 2 views

## Abstract ## Objective Treatment of patients with infliximab, a chimeric monoclonal IgG1 antibody against tumor necrosis factor, may result in the formation of infliximab‐specific IgG antibodies. This study evaluated the clinical significance of these antibodies in patients with rheumatoid arthr